Treeline Biosciences
The Biomarker Lead is responsible for planning and executing biomarker strategies across one to two clinical programs, overseeing assay development, validation, and integration of biomarker data. This role serves as the central point of accountability for biomarker deliverables, collaborating with cross‑functional teams to ensure high‑quality, timely data that supports precision medicine initiatives.
Treeline is a biotechnology company focused on engineering and controlling cell fate to enable next‑generation regenerative medicines and research tools. They combine synthetic biology, genetic payload design, and computational single‑cell analysis to create lineage‑targeted delivery platforms and programmable therapeutics that reprogram or repair tissues in vivo. Treeline partners with academic labs and biopharma to translate its platform into scalable treatments and discovery tools for degenerative and chronic diseases.
Treeline reaps $200M series A extension, plucks first 3 clinical candidates
Sep 3, 2025
Secretive startup Treeline unveils first clinical candidates, $200M in new funding
Sep 3, 2025
Treeline Announces First Clinical Trials and Secures $200M in Additional Funding
Sep 3, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Treeline Biosciences.
22% above the average for this role
Josh Bilenker’s Treeline Biosciences gets another $200M, bringing funding to $1.1B
Sep 3, 2025